Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of Muscle”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT02563561
What this trial is testing

Intravesical Apaziquone as a Surgical Adjuvant in Participant Undergoing Transurethral Resection Bladder Tumor (TURBT)

Who this might be right for
Bladder Cancer
Spectrum Pharmaceuticals, Inc 62
Not applicableLooking for participantsNCT07025213
What this trial is testing

Metabolic Effect of Exercise and Diet in Endometrial Cancer Patients Eligible for Staging Surgery.

Who this might be right for
Endometrial Cancer
National Institute of Cancerología 80
Testing effectiveness (Phase 2)Looking for participantsNCT07475403
What this trial is testing

Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder CancerLiquid BiopsyImmunotherapy
Tianjin Medical University Second Hospital 53
Large-scale testing (Phase 3)UnknownNCT03122782
What this trial is testing

Hemostatic Effect of Intrauterine Instillation Of Tranexamic Acid In Hysteroscopic Myomectomy

Who this might be right for
Surgical Blood LossFibroid
Ain Shams University 80
Very early researchStudy completedNCT04223635
What this trial is testing

Study of Pexidartinib in Participants With Moderate Hepatic Impairment Compared With Healthy Participants

Who this might be right for
Moderate Hepatic Impairment
Daiichi Sankyo 16
Large-scale testing (Phase 3)Study completedNCT03049735
What this trial is testing

LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Who this might be right for
Heavy Menstrual BleedingUterine Fibroid
Myovant Sciences GmbH 388
Not applicableNot Yet RecruitingNCT07667608
What this trial is testing

Ultrasound Assessment of Diaphragmatic Structure and Function in Patients With Liver Cirrhosis: A Point-of-Care Tool for Predicting Complications and Sarcopenia in Limited Resource Settings

Who this might be right for
Cirrhosis of the LiverAscitesPleural Effusion Disorder+3 more
Assiut University 120
Large-scale testing (Phase 3)Looking for participantsNCT06510374
What this trial is testing

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

Who this might be right for
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Ferring Pharmaceuticals 454
Early research (Phase 1)UnknownNCT00574418
What this trial is testing

Far Infrared Radiation Treatment for Uterine Fibroids

Who this might be right for
Leiomyoma
GAAD Medical Research Institute Inc. 2
Not applicableStudy completedNCT04617743
What this trial is testing

The Effect of Post-voiding Reisdual Urine on Non-muscle Invasive Bladder Cancer Recurrence and Progression

Who this might be right for
Bladder Cancer RecurrentNon-Invasive Bladder Urothelial Carcinoma
Istanbul Medeniyet University 500
Not applicableLooking for participantsNCT05739968
What this trial is testing

Impacts and Testing of the "Multi-domains Active-living Program" in Operable Non-Muscle Invasive Bladder Cancer Patients

Who this might be right for
Bladder CancerQuality of Life
National Taiwan University Hospital 120
Not applicableNot Yet RecruitingNCT06154590
What this trial is testing

Anastrozole Adjuvant Trial - Study of Anastrozole Compared to NOLVADEX (Tamoxifen Citrate) for Adjuvant Treatment of Early Breast Cancer Clinical Studies), Adjunct Cytotoxic Chemotherapy and Malignant Joint Tumor

Who this might be right for
Metastatic Breast CancerTumorMuscle Neoplasms+1 more
DR. DIANE CHISESI NFS. MD. PHD. 100
Early research (Phase 1)Study completedNCT01585649
What this trial is testing

PK/PD of XM22 in Children With Ewing Family of Tumors or Rhabdomyosarcoma

Who this might be right for
Ewing Family of Tumors, Rhabdomyosarcoma
Merckle GmbH 21
Not applicableLooking for participantsNCT07622914
What this trial is testing

The Role of Dietary Fiber in Mitigating Sarcopenia Risk in Head and Neck Cancer

Who this might be right for
Head and Neck Cancers
University of Oklahoma 59
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07151560
What this trial is testing

Efficacy and Safety of Two Bladder-preserving Treatment Durations With Disitamab Vedotin Plus Toripalimab Combination in Her2-expressing Muscle-invasive Bladder Cancer: A Phase II, Open-Label, Randomized Clinical Trial

Who this might be right for
Urology
Renmin Hospital of Wuhan University 60
Not applicableLooking for participantsNCT04806620
What this trial is testing

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

Who this might be right for
Post-Acute COVID-19 SyndromeME/CFSRheumatic Arthritis+41 more
Brain Inflammation Collaborative 10,000
Not applicableStudy completedNCT03789682
What this trial is testing

CD155 in Bladder Cancer

Who this might be right for
Bladder Cancer
Fudan University 151
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06829823
What this trial is testing

Clinical Trial of Ablation Therapy in Participants With Intermediate-Risk Non-Muscle Invasive Papillary Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
ImmunityBio, Inc. 20
Large-scale testing (Phase 3)Ended earlyNCT04197986
What this trial is testing

Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations

Who this might be right for
Upper Tract Urothelial CarcinomasUrothelial Bladder Cancer
QED Therapeutics, a BridgeBio company 39
Testing effectiveness (Phase 2)Study completedNCT00400569
What this trial is testing

Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma

Who this might be right for
LiposarcomaLeiomyosarcomaFibrosarcoma+1 more
H. Lee Moffitt Cancer Center and Research Institute 48
Next Page